Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Seres Therapeutics, Inc.”

27 pharma patents match "Seres Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 27
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 27 pharmaceutical patents matching "Seres Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

27 results for “Seres Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12409197

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted
  2. US 12214002

    Compositions and methods for treating antibiotic resistance

    Seres Therapeutics, Inc. · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  3. US 12083151

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  4. US 11918612

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  5. US 11730775

    Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof

    Seres Therapeutics, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  6. US 11701394

    Compositions and methods for treating cholestatic disease

    Seres Therapeutics, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  7. US 11666612

    Network-based microbial compositions and methods

    Seres Therapeutics, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  8. US 11464812

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  9. US 11458173

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  10. US 11458174

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  11. US 11389490

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted
  12. US 11266699

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  13. US 11185562

    Compositions and methods for inhibition of pathogenic bacterial growth

    Seres Therapeutics, Inc. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  14. US 10973861

    Compositions and methods

    Seres Therapeutics, Inc. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  15. US 10967011

    Compositions and methods

    Seres Therapeutics, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  16. US 10881696

    Network-based microbial compositions and methods

    Seres Therapeutics, Inc. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  17. US 10864235

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted
  18. US 10258655

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted
  19. US 10076546

    Network-based microbial compositions and methods

    Seres Therapeutics, Inc. · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  20. US 10064900

    Methods of populating a gastrointestinal tract

    Seres Therapeutics, Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  21. US 10064901

    Compositions and methods

    Seres Therapeutics, Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  22. US 9956282

    Bacterial compositions and methods of use thereof for treatment of immune system disorders

    Seres Therapeutics, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  23. US 9855303

    Compositions and methods

    Seres Therapeutics, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  24. US 9585921

    Compositions and methods

    Seres Therapeutics, Inc. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted